VRDN
VRDN
US92790C1045
Viridian Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 70.849.000 302.000
23359.9%
Cost of Revenue -- --
--
Gross Profit -- --
--
434.244.000 299.337.000
45.1%
Operating Income -363.395.000 -299.035.000
21.5%
Pretax Income -342.601.000 -269.949.000
26.9%
Net Income Common Stockholders -342.601.000 -269.949.000
26.9%
-- --
--
-- --
--
ende